SC
Insider
Sandra Calvin
SVP, CHIEF ACCOUNTING OFFICERSandra Calvin (SVP, CHIEF ACCOUNTING OFFICER) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $2.4M of TVTX (67,115 sh × $36.00, as filed), executed Nov 4 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.1M
shares × price, as filed
Last traded
Sep 15
Filed Sep 17
Median ADV $123.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
TVTXRecent filings
TVTXSALE
Travere Therapeutics, Inc.
View filing →
$266K4,275 sh × $62.13
Exec Sep 15
Filed Sep 17 · 9:29 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $903K
21,977 sh × $41.07
Exec Apr 14
Filed Apr 16 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $139K
4,333 sh × $32.12
Exec Feb 3
Filed Feb 3 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $296K
7,402 sh × $40.00
Exec Dec 24 2025
Filed Dec 29 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $105K
2,910 sh × $36.00
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $2.4M
67,115 sh × $36.00
Exec Nov 4 2025
Filed Nov 6 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $1.4M
54,244 sh across 5 lots
Exec Feb 11 2025
Filed Feb 12 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $258K
15,000 sh × $17.22
Exec Dec 26 2024
Filed Dec 27 2024 · 5:30 PM ET More filings →